Dyne Therapeutics, Inc. (DYN) Social Stream
DYNE THERAPEUTICS INC (DYN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DYNE THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-10 | 4 | $47 | $29 | $34.75 | $13.16 | 164.06% |
| 2022-05-23 | 4 | $47 | $16 | $28.75 | $13.16 | 118.47% |
| 2022-08-09 | 6 | $47 | $15 | $24.666 | $13.16 | 87.43% |
| 2022-08-10 | 6 | $47 | $15 | $24.833 | $13.16 | 88.7% |
| 2022-11-03 | 6 | $47 | $15 | $25.833 | $13.16 | 96.3% |
| 2022-11-06 | 6 | $47 | $16 | $26 | $13.16 | 97.57% |
| 2022-11-30 | 7 | $47 | $16 | $25 | $13.16 | 89.97% |
| 2023-01-26 | 7 | $47 | $16 | $26.142 | $13.16 | 98.65% |
| 2023-02-14 | 8 | $47 | $16 | $27.125 | $13.16 | 106.12% |
| 2023-03-03 | 8 | $47 | $17 | $28.5 | $13.16 | 116.57% |
| 2023-03-05 | 8 | $47 | $18 | $29 | $13.16 | 120.36% |
| 2023-05-15 | 8 | $47 | $20 | $29.375 | $13.16 | 123.21% |
| 2023-08-08 | 8 | $47 | $20 | $29.25 | $13.16 | 122.26% |
| 2023-10-30 | 8 | $47 | $20 | $29.5 | $13.16 | 124.16% |
| 2023-10-31 | 8 | $36 | $20 | $28.125 | $13.16 | 113.72% |
The Trend in the Analyst Price Target
DYN's average price target has moved down $8.27 over the prior 31 months.
DYN reports an average of 143.47% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 7 | 47 | 16 | 26.142 | 14.18 | 84.36% |
| 2023-02-14 | 8 | 47 | 16 | 27.125 | 13.24 | 104.87% |
| 2023-08-04 | 8 | 47 | 20 | 29.250 | 11.55 | 153.25% |
| 2023-08-09 | 8 | 47 | 20 | 29.500 | 10.58 | 178.83% |
| 2023-10-30 | 8 | 47 | 20 | 29.500 | 7.32 | 303.01% |
DYN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
DYN's average broker recommendation rating improved by 0.6 over the prior 27 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DYN as an investment opportunity.
- In the context of all US stocks, DYNE THERAPEUTICS INC's variance in analysts' estimates is lower than -1572.88% of them.
- DYNE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1553.84% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, DYNE THERAPEUTICS INC's number of analysts covering the stock is higher than 1436.18% of them.
- In the context of stocks in the small market cap category, DYNE THERAPEUTICS INC's average analyst price target is higher than 1317.34% of them.
Stocks similar to DYNE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CMPS, BIVI, and GLSI.
View All Top Stocks by Price Target
Make investment decisions regarding DYN using the data that counts. Try POWR Ratings for free.